Open access
Sep 2026
The dysregulation of a subset of microRNAs in triple-negative breast cancer is associated with poor survival following neoadjuvant chemotherapy
Introduction: Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. Despite significant research efforts, current therapies are often ineffectiv...
B. O. P. Gonçalves, B. Siqueira, F. Queiroz et al.
· Mastology · 0 citations